Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 20, 2014JAMA OphthalmologyOpen Access

Treatment Strategies in Primary Vitreoretinal Lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

ARAnjo RiemensUtrecht UniversityJBJacoline E. C. BrombergErasmus MCVTValérie TouitouNeurology, Inc

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Riemens et al. (2014) studied this question.

synapsesocial.com/papers/6a7bfdcd8add427333df79aahttps://doi.org/10.1001/jamaophthalmol.2014.4755
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites2000 · 232 citations
  2. 2Testicular lymphoma, intraocular (Vitreoretinal) lymphoma, and brain lymphoma: Involvement of three immunoprivileged sites in one patient2010 · 13 citations
  3. 3Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience2008 · 273 citations
  4. 4How I treat primary CNS lymphoma2011 · 187 citations